Obesity Surgery

, Volume 30, Issue 1, pp 174–179 | Cite as

Elevated Levels of Circulating miR-92a Are Associated with Impaired Glucose Homeostasis in Patients with Obesity and Correlate with Metabolic Status After Bariatric Surgery

  • Rubén Cereijo
  • Siri D. Taxerås
  • Irene Piquer-Garcia
  • Silvia Pellitero
  • Eva Martínez
  • Jordi Tarascó
  • Pau Moreno
  • José Balibrea
  • Manel Puig-Domingo
  • David Jiménez-Pavón
  • Carles Lerin
  • Francesc VillarroyaEmail author
  • David Sánchez-InfantesEmail author
Original Contributions



miRNAs are small non-coding RNAs, some of which are expressed in adipose tissues, are present in the circulation, and are regulated in obesity. Bariatric surgery (BS) has been proposed to lead to activation of brown adipose tissue, an effect that may be related to beneficial effects of BS on systemic metabolism. Here, we evaluated circulating levels of miR-92a and miR-99b, two miRNAs proposed as biomarkers of brown fat activity, in a cohort of patients with severe obesity before and after BS, and studied their potential relationship with BS-associated improvements in metabolic parameters.


Circulating levels of miR-92a and miR-99b were quantified in a cohort of 26 patients (age, 48 ± 10 years; BMI, 45 ± 7 kg/m2) before and 6 months after BS. Clinical parameters were determined at different time points and correlations among them were studied.


Basal levels of miR-92a were significantly increased in patients with obesity relative to lean controls. Serum miR-92a levels were strongly reduced at 6 months after BS, reaching levels similar to those in controls. Serum miR-99b levels were unchanged in relation to both the obese condition and BS. Elevated levels of miR-92a were directly correlated with worsened glucose homeostasis parameters and poor BS outcome.


Our findings show that miR-92a is elevated in conditions of obesity, and its reduction after BS correlates with metabolic improvement. Further studies would be necessary to establish miR-92a as serum biomarker and potential predictor of the BS success in improving the metabolic status of patients with obesity.


miR-92a miR-99b Obesity Bariatric surgery Brown adipose tissue 



We thank the IGTP High Content Genomics and Bioinformatics Core facility and staff (Lauro Sumoy, PhD, and Raquel Pluvinet, PhD) for their contribution to this publication.


DS-I is an Investigator of the Miguel Servet Fund from Carlos III National Institute of Health, Spain. This study was supported by the Instituto de Salud Carlos III, Ministerio de Ciencia, Innovación y Universidades, by the Fondo Europeo de Desarrollo Regional (FEDER), Madrid, Spain (FIS17/01455 and SAF2017-85722R), and by the K-sted 651010-Project number 70084900-analyze number M50676 from Norwegian University of Science and Technology (NTNU). DJP was supported by a grant from the Spanish Ministry of Science and Innovation - MINECO (RYC-2014-16938).

Compliance with Ethical Standards

Samples from patients included in this study were provided by the IGTP HUGTP Biobank and the “Biobanc de l’Hospital Infantil Sant Joan de Déu per a la Investigació,” both integrated in the Spanish National Biobanks Network of Instituto de Salud Carlos III (PT13/0010/0009) and they were processed following standard operating procedures with the appropriate approval of the Ethical and Scientific Committees.

Conflict of Interest

Francesc Villarroya reports grants from Ministerio de Ciencia, Innovació y Universidades, outside the submitted work. The other authors declare that they have no competing interests.


  1. 1.
    Villarroya J, Cereijo R, Villarroya F. An endocrine role for brown adipose tissue? Am J Physiol Endocrinol Metab. 2013;305(5):E567–72.CrossRefGoogle Scholar
  2. 2.
    Bartelt A, Bruns OT, Reimer R, et al. Brown adipose tissue activity controls triglyceride clearance. Nat Med. 2011;17(2):200–5.CrossRefGoogle Scholar
  3. 3.
    Peirce V, Vidal-Puig A. Regulation of glucose homoeostasis by brown adipose tissue. Lancet Diabetes Endocrinol. 2013;1(4):353–60.CrossRefGoogle Scholar
  4. 4.
    Villarroya F, Cereijo R, Villarroya J, et al. Brown adipose tissue as a secretory organ. Nat Rev Endocrinol. 2017;13(1):26–35.CrossRefGoogle Scholar
  5. 5.
    Cypess AM, Lehman S, Williams G, et al. Identification and importance of brown adipose tissue in adult humans. N Engl J Med. 2009;360(15):1509–17.CrossRefGoogle Scholar
  6. 6.
    Saito M, Okamatsu-Ogura Y, Matsushita M, et al. High incidence of metabolically active brown adipose tissue in healthy adult humans: effects of cold exposure and adiposity. Diabetes. 2009;58(7):1526–31.CrossRefGoogle Scholar
  7. 7.
    Van Marken Lichtenbelt WD, Vanhommerig JW, Smulders NM, et al. Cold-activated brown adipose tissue in healthy men. N Engl J Med. 2009;360(15):1500–8.CrossRefGoogle Scholar
  8. 8.
    Virtanen KA, Lidell ME, Orava J, et al. Functional brown adipose tissue in healthy adults. N Engl J Med. 2009;360:1518–25.CrossRefGoogle Scholar
  9. 9.
    Pontiroli AE, Morabito A. Long-term prevention of mortality in morbid obesity through bariatric surgery: a systematic review and meta-analysis of trials performed with gastric banding and gastric bypass. Ann Surg. 2011;253(3):484–7.CrossRefGoogle Scholar
  10. 10.
    Cummings DE, Cohen RV. Bariatric/metabolic surgery to treat type 2 diabetes in patients with a BMI <35 kg/m2. Diabetes Care. 2016;39(6):924–33.CrossRefGoogle Scholar
  11. 11.
    Vijgen GH, Bouvy ND, Teule GJ, et al. Increase in brown adipose tissue activity after weight loss in morbidly obese subjects. J Clin Endocrinol Metab. 2012;97(7):E1229–33.CrossRefGoogle Scholar
  12. 12.
    Rachid B, van de Sande-Lee S, Rodovalho S, et al. Distinct regulation of hypothalamic and brown/beige adipose tissue activities in human obesity. Int J Obes. 2015;39(10):1515–22.CrossRefGoogle Scholar
  13. 13.
    Chen KY, Cypess AM, Laughlin MR, et al. Brown Adipose Reporting Criteria in Imaging STudies (BARCIST 1.0): recommendations for standardized FDG-PET/CT experiments in humans. Cell Metab. 2016;24(2):210–22.CrossRefGoogle Scholar
  14. 14.
    Meister G, Tuschl T. Mechanisms of gene silencing by double-stranded RNA. Nature. 2004;431(7006):343–9.CrossRefGoogle Scholar
  15. 15.
    Mello CC, Conte Jr D. Revealing the world of RNA interference. Nature. 2004;431(7006):338–42.CrossRefGoogle Scholar
  16. 16.
    Pfeifer A, Lehmann H. Pharmacological potential of RNAi—focus on miRNA. Pharmacol Ther. 2010;126(3):217–27.CrossRefGoogle Scholar
  17. 17.
    Arroyo JD, Chevillet JR, Kroh EM, et al. Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma. Proc Natl Acad Sci U S A. 2011;108(12):5003–8.CrossRefGoogle Scholar
  18. 18.
    Hilton C, Neville MJ, Karpe F. MicroRNAs in adipose tissue: their role in adipogenesis and obesity. Int J Obes. 2013;37(3):325–32.CrossRefGoogle Scholar
  19. 19.
    Trajkovski M, Ahmed K, Esau CC, et al. MyomiR-133 regulates brown fat differentiation through Prdm16. Nat Cell Biol. 2012;14(12):1330–5.CrossRefGoogle Scholar
  20. 20.
    Pan D, Mao C, Quattrochi B, et al. MicroRNA-378 controls classical brown fat expansion to counteract obesity. Nat Commun. 2014;5:4725.CrossRefGoogle Scholar
  21. 21.
    Chen Y, Siegel F, Kipschull S, et al. miR-155 regulates differentiation of brown and beige adipocytes via a bistable circuit. Nat Commun. 2013;4:1769.CrossRefGoogle Scholar
  22. 22.
    Chen Y, Buyel JJ, Hanssen MJ, et al. Exosomal microRNA miR-92a concentration in serum reflects human brown fat activity. Nat Commun. 2016;7:11420.CrossRefGoogle Scholar
  23. 23.
    Fischer AP, Seeger D, Bonauer T, et al. Genetic deletion and pharmacological inhibition of MiR-92a reduce obesity. Circulation. 2014;130:A16501.Google Scholar
  24. 24.
    Thomou T, Mori MA, Dreyfuss JM, et al. Adipose-derived circulating miRNAs regulate gene expression in other tissues. Nature. 2017;542(7642):450–5.CrossRefGoogle Scholar
  25. 25.
    Sabench Pereferrer F, Domínguez-Adame Lanuza E, Ibarzabal A, Socas Macias M, ValentíAzcárate V, García Ruiz de Gordejuela, et al. Quality criteria in bariatric surgery: consensus review and recommendations of the Spanish Association of Surgeons and the Spanish Society of Bariatric Surgery. Cir Esp 2017;95(1):4–16.Google Scholar
  26. 26.
    Lirun K, Sewe M, Yong W. A pilot study: the effect of Roux-en-Y gastric bypass on the serum microRNAs of the type 2 diabetes patient. Obes Surg. 2015;25(12):2386–92.CrossRefGoogle Scholar
  27. 27.
    Finck BN. Targeting metabolism, insulin resistance, and diabetes to treat nonalcoholic steatohepatitis. Diabetes. 2018;67(12):2485–93.CrossRefGoogle Scholar
  28. 28.
    Carreras-Badosa G, Bonmatí A, Ortega FJ, et al. Altered circulating miRNA expression profile in pregestational and gestational obesity. J Clin Endocrinol Metab. 2015;100(11):E1446–56.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2019

Authors and Affiliations

  • Rubén Cereijo
    • 1
    • 2
  • Siri D. Taxerås
    • 3
  • Irene Piquer-Garcia
    • 3
  • Silvia Pellitero
    • 3
    • 4
  • Eva Martínez
    • 3
  • Jordi Tarascó
    • 3
  • Pau Moreno
    • 3
  • José Balibrea
    • 5
  • Manel Puig-Domingo
    • 3
    • 4
  • David Jiménez-Pavón
    • 6
    • 7
  • Carles Lerin
    • 8
  • Francesc Villarroya
    • 1
    • 2
    • 8
    Email author
  • David Sánchez-Infantes
    • 3
    Email author
  1. 1.Department of Biochemistry and Molecular Biomedicine, Institute of BiomedicineUniversity of BarcelonaBarcelonaSpain
  2. 2.Centro de Investigación Biomédica en Red de Fisiopatología de la Obesidad y la Nutrición (CIBEROBN)Instituto de Salud Carlos IIIBarcelonaSpain
  3. 3.Germans Trias i Pujol Research InstituteCampus Can Ruti, Carretera de Can RutiBarcelonaSpain
  4. 4.Biomedical Research Center (Red Fisiopatología de la Diabetes y enfermedades metabólicas) (CIBERDEM), ISCIIIMadridSpain
  5. 5.Metabolic and Bariatric Surgery Unit, EAC-BS Center of ExcellenceVall d’Hebron University HospitalBarcelonaSpain
  6. 6.MOVE-IT Research group and Department of Physical Education, Faculty of Education SciencesUniversity of CádizCádizSpain
  7. 7.Institute of Research and Innovation in Biomedical Sciences of the Province of Cádiz (INiBICA)University of CádizCádizSpain
  8. 8.Institut de Recerca Sant Joan de DéuBarcelonaSpain

Personalised recommendations